Biotechnology company
Appears in 1 story · Last updated Nov 10, 2026
Being acquired
Every medicine argenx sells today reaches patients by infusion or injection. On Nov. 9, 2026, the Dutch immunology company agreed to pay $550 million in cash for a Santa Cruz company whose chemistry is built to make pills instead.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
